Figure 2From: Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cellsLobaplatin arrested cell cycle progression in G 1 and G 2 /M phases time-dependently. SMMC-7721 cells were treated with 1.45 μg/ml lobaplatin. In the course of treatment, cell cycle distribution was analyzed by FCM at 0, 24, 36, and 48 h. The profiles showed dual-variable plots of cell number versus PI uptake. G1, S, and G2/M cell populations were quantified.Back to article page